查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386418

静脉疾病治疗市场报告：2030 年趋势、预测与竞争分析

Venous Diseases Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

静脉疾病治疗的趋势与预测

预计到 2030 年，全球静脉疾病治疗市场将达到约 91 亿美元，2024 年至 2030 年年复合成长率为 6.5%。该市场的主要驱动因素是静脉疾病盛行率的增加、人们对静脉疾病的认识不断提高以及医疗保健支出的增加。全球静脉疾病治疗市场包括硬化治疗、射频消融、雷射治疗、门诊静脉曲张切除术、静脉结扎/解剖、血管成形术或置入术、手术、压迫疗法、静脉促效剂和未来性是有希望的。

静脉疾病治疗市场洞察

Lucintel 预测，由于静脉曲张病例的增加和治疗静脉曲张的微创手术，静脉曲张仍将是最大的部分。

在这个市场中，雷射治疗预计将在预测期内呈现最高成长。这是由于对治疗时间较短的微创手术的需求不断增加，以及治疗静脉疾病的技术不断发展。

由于美国口中静脉曲张疾病的增加、人口高龄化的显着增长以及诊断和治疗技术的进步，北美可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球静脉疾病治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球静脉疾病治疗市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球静脉疾病治疗市场
    • 硬化剂注射
    • 消融装置
    • 静脉缝合产品
    • 静脉支架
    • 药品
    • 其他的
  • 按疾病类型分類的全球静脉疾病治疗市场
    • 深层静脉栓塞症
    • 慢性静脉功能不全
    • 肺动脉栓塞
    • 血栓性浅静脉炎
    • 静脉曲张
    • 其他的
  • 按治疗类型分類的全球静脉疾病治疗市场
    • 硬化疗法
    • 射频消融术治疗
    • 雷射治疗
    • 切除术切除术
    • 静脉结扎和剥离
    • 血管成形术或置入术
    • 外科手术
    • 压迫疗法
    • 其他的
  • 按最终用途分類的全球静脉疾病治疗市场
    • 医院
    • 诊所
    • 门诊手术中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球静脉疾病治疗市场（按地区）
  • 北美静脉疾病治疗市场
  • 欧洲静脉疾病治疗市场
  • 亚太静脉疾病治疗市场
  • 其他区域性静脉疾病治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球静脉疾病治疗市场成长机会
    • 按疾病类型分類的全球静脉疾病治疗市场成长机会
    • 全球静脉疾病治疗市场成长机会（依治疗类型）
    • 全球静脉疾病治疗市场的成长机会（依最终用途）
    • 全球静脉疾病治疗市场按地区成长机会
  • 全球静脉疾病治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球静脉疾病治疗市场的产能
    • 全球静脉疾病治疗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus
简介目录

Venous Diseases Treatment Trends and Forecast

The future of the global venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets. The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

A more than 150-page report is developed to help in your business decisions.

Venous Diseases Treatment by Segment

The study includes a forecast for the global venous diseases treatment by product type, disease type, treatment type, end use, and region.

Venous Diseases Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sclerotherapy Injection
  • Ablation Devices
  • Venous Closure Products
  • Venous Stents
  • Medication
  • Others

Venous Diseases Treatment Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Deep Vein Thrombosis
  • Chronic Venous Insufficiency
  • Pulmonary Embolism
  • Superficial Thrombophlebitis
  • Varicose Veins
  • Others

Venous Diseases Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sclerotherapy
  • Radiofrequency Ablation Therapy
  • Laser Treatment
  • Ambulatory Phlebectomy
  • Vein Ligation & Stripping
  • Angioplasty Or Stenting
  • Surgeries
  • Compression Therapy
  • Others

Venous Diseases Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Venous Diseases Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Venous Diseases Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies venous diseases treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the venous diseases treatment companies profiled in this report include-

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus

Venous Diseases Treatment Market Insights

Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Within this market, laser treatment is expected to witness highest growth over the forecast period due to rising demand for minimal invasive procedure with less cure time and om-going technological development to treat venous diseases.

North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Features of the Global Venous Diseases Treatment Market

Market Size Estimates: Venous diseases treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Venous diseases treatment market size by various segments, such as by product type, disease type, treatment type, end use, and region in terms of ($B).

Regional Analysis: Venous diseases treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, disease types, treatment types, end uses, and regions for the venous diseases treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the venous diseases treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the venous diseases treatment market size?

Answer: The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for venous diseases treatment market?

Answer: The global venous diseases treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the venous diseases treatment market?

Answer: The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

Q4. What are the major segments for venous diseases treatment market?

Answer: The future of the venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets.

Q5. Who are the key venous diseases treatment market companies?

Answer: Some of the key venous diseases treatment companies are as follows:

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus

Q6. Which venous diseases treatment market segment will be the largest in future?

Answer: Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Q7. In venous diseases treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the venous diseases treatment market by product type (sclerotherapy injection, ablation devices, venous closure products, venous stents, medication, and others), disease type (deep vein thrombosis, chronic venous insufficiency, pulmonary embolism, superficial thrombophlebitis, varicose veins, and others), treatment type (sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, and others), end use (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Venous Diseases Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Venous Diseases Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Venous Diseases Treatment Market by Product Type
    • 3.3.1: Sclerotherapy Injection
    • 3.3.2: Ablation Devices
    • 3.3.3: Venous Closure Products
    • 3.3.4: Venous Stents
    • 3.3.5: Medication
    • 3.3.6: Others
  • 3.4: Global Venous Diseases Treatment Market by Disease Type
    • 3.4.1: Deep Vein Thrombosis
    • 3.4.2: Chronic Venous Insufficiency
    • 3.4.3: Pulmonary Embolism
    • 3.4.4: Superficial Thrombophlebitis
    • 3.4.5: Varicose Veins
    • 3.4.6: Others
  • 3.5: Global Venous Diseases Treatment Market by Treatment Type
    • 3.5.1: Sclerotherapy
    • 3.5.2: Radiofrequency ablation therapy
    • 3.5.3: Laser Treatment
    • 3.5.4: Ambulatory Phlebectomy
    • 3.5.5: Vein Ligation & stripping
    • 3.5.6: Angioplasty or Stenting
    • 3.5.7: Surgeries
    • 3.5.8: Compression Therapy
    • 3.5.9: Others
  • 3.6: Global Venous Diseases Treatment Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Clinics
    • 3.6.3: Ambulatory Surgical Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Venous Diseases Treatment Market by Region
  • 4.2: North American Venous Diseases Treatment Market
    • 4.2.1: North American Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.2.2: North American Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.3: European Venous Diseases Treatment Market
    • 4.3.1: European Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.3.2: European Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.4: APAC Venous Diseases Treatment Market
    • 4.4.1: APAC Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.4.2: APAC Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.5: ROW Venous Diseases Treatment Market
    • 4.5.1: ROW Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.5.2: ROW Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Venous Diseases Treatment Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Venous Diseases Treatment Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Venous Diseases Treatment Market by Treatment Type
    • 6.1.4: Growth Opportunities for the Global Venous Diseases Treatment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Venous Diseases Treatment Market by Region
  • 6.2: Emerging Trends in the Global Venous Diseases Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Venous Diseases Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Venous Diseases Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Imricor
  • 7.3: Medtronic
  • 7.4: Stryker
  • 7.5: Koninklijke Philips
  • 7.6: Baylis Medical
  • 7.7: Theraclion
  • 7.8: Sonablate
  • 7.9: Boston Scientific
  • 7.10: Olympus